Showing results (671-680 of 7,629) with videos related to
Sort By:
Pageof 763
American Journal of Hematology|April 23, 2014
The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studiesSophia Fircanis, Priscilla Merriam, Naushaba Khan, et al.American Journal of Hematology|April 24, 2014
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patientsEirini Katodritou, Evangelos Terpos, Argiris S Symeonidis, et al.American Journal of Hematology|April 24, 2014
Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patientsChindu Govindaraj, Mutsa Madondo, Ying Ying Kong, et al.American Journal of Hematology|March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaHeather L Gustafson, Song Yao, Bryan H Goldman, et al.American Journal of Hematology|March 1, 1989
Differential nucleolus organizer activity in normal and leukemic bone marrowK C Arden, D A Johnston, A Cork, et al.American Journal of Hematology|August 1, 1988
CD5 positive immunoregulatory B cell subsetsT Paglieroni, V Caggiano, M MacKenzieAmerican Journal of Hematology|March 2, 2017
BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximabSarah Huet, Edith Szafer-Glusman, Bruno Tesson, et al.American Journal of Hematology|February 28, 2017
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohortGuillaume Moulis, Johanne Germain, Thibault Comont, et al.American Journal of Hematology|October 1, 1987
Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodiesF R Davey, W N Erber, K C Gatter, et al.American Journal of Hematology|January 5, 2017
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myelomaArnold Bolomsky, Wolfgang Hübl, Stefano Spada, et al.Pageof 763